Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001104659-26-112058

Chief Financial Officer sold 3,377 shares at $36.57 ($123,497)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roberts Brandi Chief Financial Officer 2026-09-25 Sale 10b5-1 −3,377 $36.57 $123,497 394,528 D: show line 1 in the form
Open-market sales · 3,377 sh · avg $36.57 · $123,497
Loading xslF345X06/tm2626627-1_4seq1.xml…